about
Guidelines for the use and interpretation of assays for monitoring autophagyBax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondriaBcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDACA novel role for high-mobility group a proteins in cellular senescence and heterochromatin formationAutophagy mediates the mitotic senescence transitionOld cells, new tricks: chromatin structure in senescence14-3-3 Interacts directly with and negatively regulates pro-apoptotic BaxLet-7 repression leads to HMGA2 overexpression in uterine leiomyosarcomaCELL BIOLOGY. GATA get a hold on senescenceQuantitation and Identification of Thousands of Human Proteoforms below 30 kDaNormalization of metabolomics data with applications to correlation maps.NOTCH1 mediates a switch between two distinct secretomes during senescence.Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescenceIndependence of repressive histone marks and chromatin compaction during senescent heterochromatic layer formation.p400 is required for E1A to promote apoptosis.Histone H3.3 and its proteolytically processed form drive a cellular senescence programmeSASP reflects senescence.NG2 expression in glioblastoma identifies an actively proliferating population with an aggressive molecular signature.Phenotype specific analyses reveal distinct regulatory mechanism for chronically activated p53Reversal of human cellular senescence: roles of the p53 and p16 pathways.HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genesIdentification of a Selective G1-Phase Benzimidazolone Inhibitor by a Senescence-Targeted Virtual Screen Using Artificial Neural Networks.Retinoblastoma protein promotes oxidative phosphorylation through upregulation of glycolytic genes in oncogene-induced senescent cells.Cellular senescence and chromatin organisation.Oncogenes and senescence: breaking down in the fast lane.Oncogenic HMGA2: short or small?Redistribution of the Lamin B1 genomic binding profile affects rearrangement of heterochromatic domains and SAHF formation during senescence.Multiple expression cassette exchange via TP901-1, R4, and Bxb1 integrase systems on a mouse artificial chromosomeQuality and quantity control of proteins in senescence.Impact of cellular senescence signature on ageing research.Autophagy in cancer: having your cake and eating it.Cancer cell senescence: a new frontier in drug development.Cell senescence as both a dynamic and a static phenotype.Cellular senescence and its effector programs.Inside and out: the activities of senescence in cancer.A 'synthetic-sickness' screen for senescence re-engagement targets in mutant cancer backgroundsG-quadruplex structures mark human regulatory chromatin.Quantitative assessment of higher-order chromatin structure of the INK4/ARF locus in human senescent cells.Metabolomic changes during cellular transformation monitored by metabolite-metabolite correlation analysis and correlated with gene expression.Direct coupling of the cell cycle and cell death machinery by E2F.
P50
Q21996341-FDC4185E-7700-495F-8A17-74F265DF2948Q22008484-A45F104D-91E3-4603-BDE3-4F7AB569B164Q22009974-1B825FC1-094F-4D98-A1DD-21F8294379A3Q24299446-A0562E36-301E-45EF-9E62-02279D86FEEFQ24320401-528ED594-482A-438F-A7DB-D0251500E6EAQ26750501-46BD7AA9-3C3D-4AA8-B0C5-3156E99F7987Q28214507-88DC51D8-A14E-4D75-B03A-9AAB2C43AE8CQ28251930-8B62131E-8BB3-490F-916C-B086C906CA74Q28267760-60FC9983-B1A7-4404-80EC-C93A445094AAQ29029578-1EF5BB3A-D7C8-44EC-AA80-A8DE7F0EF8ECQ30796282-123D434F-FC45-4ECF-967C-318D01FB1D08Q30806890-C029CA2A-4C3C-4326-A080-7BA20AD6BA22Q33929054-586E5ECF-9792-4ECC-ABDF-9A7078AF6478Q34337209-5AE2466A-677C-4A0C-A9D7-C9BC9896E49DQ34399239-D7EFFD4E-8875-4374-BB84-94C6F0088322Q34533167-75A2F0A5-58AC-436B-B132-2EB1E77140F8Q34945503-E69B9EDA-015A-4431-9ADA-9C609537D489Q35133431-C3D8CEA5-42F2-49B5-AD9D-9FDCBD94FF39Q35196159-7552AB29-0695-43D3-B64D-78528F54720AQ35561999-5BC48EEE-E357-4F5E-9F8D-F2F3789E5D62Q35615694-03843142-C69E-4026-8832-3A6A09FD0EBDQ35811361-8BD41BF6-73BF-4E52-8383-E63098B3AB23Q35935196-B73656E5-6413-42A3-835C-5DD5C2BB752DQ36609955-B2556656-FDA0-40DC-8FBA-751F123C9561Q36702441-432B5D32-2521-47FF-ADFD-2114D8AD0A8EQ36808432-E77B5F80-2270-49F9-9BE9-C475E1662E1CQ37138585-A7A99B47-10AB-4D08-B383-EEE84D480FC5Q37681644-2A1F89EC-1DC5-4EC8-B740-1CA16FBDD7FCQ37762358-9E1FF986-26A1-42E4-A6A5-32812FB54180Q37800219-AC7DEF77-1E27-4098-9C77-155F36DA4E53Q37938309-2D79D0CF-E5A9-415F-8C74-6332A0698274Q37982201-2E690CE5-96C9-41BB-9B1C-7E34D82CE15DQ38072349-28DECFFF-580F-4002-891C-AF670D13E523Q38180648-3C87EF8B-37F5-4890-9F3F-AFDECFCD5F75Q38230319-B25105AC-E15E-49E6-BF0B-DB2CF8626BE3Q38694968-12329AD3-11E3-4BE8-8658-517A36ED5082Q38746800-45DF8AEA-7C32-4625-8131-EB302E3D199FQ39395750-0B015D14-033F-496D-9DAE-94D6DE3AE472Q40403745-9EA5C53F-DA15-426F-B199-2722B6C5F2BFQ40695864-E6096A03-BE37-482F-9C70-18D0E2537F93
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Masashi Narita
@ast
Masashi Narita
@en
Masashi Narita
@es
Masashi Narita
@nl
Masashi Narita
@sl
type
label
Masashi Narita
@ast
Masashi Narita
@en
Masashi Narita
@es
Masashi Narita
@nl
Masashi Narita
@sl
prefLabel
Masashi Narita
@ast
Masashi Narita
@en
Masashi Narita
@es
Masashi Narita
@nl
Masashi Narita
@sl
P106
P1153
8982438100
P31
P496
0000-0001-7764-577X